BioCentury | Jan 12, 2021
Deals
Jan. 11 Quick Takes: Inmagene gains options to four Chi-Med immunology programs; plus Zai-Turning Point, Mirati-Resolution, GSK-Eligo, Biogen-Apple, Adaptive-AZ and more
...suppressor 2
BC Staff
Inmagene Biopharmaceuticals Co. Ltd.
Hutchison China MediTech Ltd.
Zai Lab Ltd.
Turning Point Therapeutics Inc.
Mirati Therapeutics Inc.
Resolution Biomedical Inc.
GlaxoSmithKline...
